BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 17312132)

  • 21. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.
    Liu T; Soong L; Liu G; König R; Chopra AK
    Biol Direct; 2009 Oct; 4():40. PubMed ID: 19852824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
    Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
    Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.
    Ghiringhelli F; Puig PE; Roux S; Parcellier A; Schmitt E; Solary E; Kroemer G; Martin F; Chauffert B; Zitvogel L
    J Exp Med; 2005 Oct; 202(7):919-29. PubMed ID: 16186184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
    Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against autoimmunity in nonlymphopenic hosts by CD4+ CD25+ regulatory T cells is antigen-specific and requires IL-10 and TGF-beta.
    Huang X; Zhu J; Yang Y
    J Immunol; 2005 Oct; 175(7):4283-91. PubMed ID: 16177068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines.
    Ueda R; Fujita M; Zhu X; Sasaki K; Kastenhuber ER; Kohanbash G; McDonald HA; Harper J; Lonning S; Okada H
    Clin Cancer Res; 2009 Nov; 15(21):6551-9. PubMed ID: 19861464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4(+)CD25(+) regulatory T cells attenuate Hypersensitivity Pneumonitis by suppressing IFN-gamma production by CD4(+) and CD8(+) T cells.
    Park Y; Oh SJ; Chung DH
    J Leukoc Biol; 2009 Dec; 86(6):1427-37. PubMed ID: 19741155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The suppressive effect of CD25+Treg cells on Th1 differentiation requires cell-cell contact partially via TGF-β production.
    Shen E; Zhao K; Wu C; Yang B
    Cell Biol Int; 2011 Jul; 35(7):705-12. PubMed ID: 21314640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells.
    Klunker S; Chong MM; Mantel PY; Palomares O; Bassin C; Ziegler M; Rückert B; Meiler F; Akdis M; Littman DR; Akdis CA
    J Exp Med; 2009 Nov; 206(12):2701-15. PubMed ID: 19917773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.
    Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
    J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Th17 and CD4
    Xiang M; Guo L; Ma Y; Li Y
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease.
    Wong M; La Cava A; Hahn BH
    J Immunol; 2013 Jun; 190(11):5402-10. PubMed ID: 23636058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor-beta and all-trans retinoic acid generate ex vivo transgenic regulatory T cells with intestinal homing receptors.
    Moore C; Sauma D; Morales J; Bono MR; Rosemblatt M; Fierro JA
    Transplant Proc; 2009; 41(6):2670-2. PubMed ID: 19715998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A; Beissert S; Krammer PH
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intestinal microbiota on the induction of regulatory CD25+ CD4+ T cells.
    Ishikawa H; Tanaka K; Maeda Y; Aiba Y; Hata A; Tsuji NM; Koga Y; Matsumoto T
    Clin Exp Immunol; 2008 Jul; 153(1):127-35. PubMed ID: 18460018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human ovarian carcinoma cells generate CD4(+)CD25(+) regulatory T cells from peripheral CD4(+)CD25(-) T cells through secreting TGF-beta.
    Li X; Ye F; Chen H; Lu W; Wan X; Xie X
    Cancer Lett; 2007 Aug; 253(1):144-53. PubMed ID: 17353088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells.
    Yamanishi H; Murakami H; Ikeda Y; Abe M; Kumagi T; Hiasa Y; Matsuura B; Onji M
    J Immunol; 2012 Mar; 188(5):2164-72. PubMed ID: 22291189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.